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Background: Asthma is an inflammatory condition characterized by airway hyperresponsiveness and chronic
inflammation. The resolution of inflammation is an essential process to treat this condition. In this study we
investigated the effect of Allium cepa L. extract (AcE) and quercetin (Qt) on cytokine and on smooth muscle
contraction in vitro and its therapeutic potential in a murine model of asthma.
Methods: AcE was obtained by maceration of Allium cepa L. and it was standardized in terms of quercetin
concentration using high performance liquid chromatography (HPLC). In vitro, using AcE 10, 100 or 1000 μg/ml or
Qt 3.5, 7.5, 15 μg/ml, we measured the concentration of cytokines in spleen cell culture supernatants, and the
ability to relax tracheal smooth muscle from A/J mice. In vivo, Blomia tropicalis (BT)-sensitized A/J mice were treated
with AcE 100, 1000 mg/kg or 30 mg/kg Qt. We measured cell influx in bronchoalveolar lavage (BAL), eosinophil
peroxidase (EPO) in lungs, serum levels of Bt-specific IgE, cytokines levels in BAL, and lung histology.
Results: We observed a reduction in the production of inflammatory cytokines, a relaxation of tracheal rings, and a
reduction in total number of cells in BAL and EPO in lungs by treatment with AcE or Qt.
Conclusion: AcE and Qt have potential as antiasthmatic drugs, as they possess both immunomodulatory and
bronchodilatory properties.
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Asthma is an inflammatory condition characterized by
airway hyperresponsiveness, mucus cell hyperplasia, in-
flammatory cell infiltration and reversible bronchocon-
striction, which may progress to airway remodeling with
fibrosis and an increase in smooth muscle reactivity
[1-4]. In allergic asthma, exposure to allergens causes an
imbalance between the T helper type (Th) 1 and Th2 re-
sponses. Cytokines produced by the Th2-type CD4 + T
cells (interleukin (IL-4, IL-5, IL-13) in asthma have a
central role in orchestrating the inflammatory response.* Correspondence: cavfigueiredo@gmail.com
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unless otherwise stated.Strong support for this T-cell-centric paradigm has been
enriched by the identification of Treg cells with the cap-
acity to control both Th1 and Th2 responses [5]. The syn-
thesis and release of IL-4 (which stimulates B cells to
synthesize IgE), IL-13 (which stimulates mucus produc-
tion) and IL-5 (which is necessary for eosinophilic infiltra-
tion to the lung tissue) increase vascular permeability and
chemotaxis, which amplify the inflammatory response.
Additionally, activated mast cells are able during an aller-
gen challenge to release several inflammatory and bronch-
oconstrictor mediators [6,7].
The prevalence of asthma continues to rise worldwide
[8], and treatment of asthma faces many challenges, in-
cluding under diagnosis, access to care, ability of health-
care workers to manage asthma, education of healthcare. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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inhaled therapy [9]. Treatment with inhaled steroids and
bronchodilators often results in good control of symptoms
[10]. However, the treatment for patients with severe
asthma with uncontrolled and frequent exacerbations still
contributes to morbidity and mortality of asthma in all age
groups and remains a challenge [11,12]. The safety con-
cerns and the obstacles for the asthmatic patients justify
continued efforts to find new alternative therapies [13].
Historically, herbal medicine has been studied in asthma
treatment, and some of the drugs currently used to treat
this disease such as the inhaled corticosteroids, sympatho-
mimetics, anti-cholinergics, methylxanthines and cro-
mones have origins in herbal treatments [14]. Thus, our
group performed an ethnopharmacological survey [15],
and one of the herbs described was Allium cepa L., com-
monly used to treat inflammatory conditions such as
asthma [16,17].
Several plant-derived secondary metabolites have been
shown to interfere directly with molecules and mecha-
nisms, such as the mediation of inflammatory responses
and activity of second messengers, as well as the expres-
sion of transcription factors and key pro-inflammatory
molecules [18]. The main compounds found in Allium
cepa L. extract (AcE) are the flavonoids such as quer-
cetin, which are natural phenolic compounds present in
fruits and vegetables, exhibiting many pharmacological
properties such as its anti-inflammatory and antioxidant
effects [17,19-21]. Along with flavanols, the major bio-
active constituents in Allium cepa L. are sulfurous com-
pounds. In previous studies, using mass spectrometry
for direct analysis of volatile sulfurous compounds has
described the presence of propanethiol, dipropyl disul-
fide and thiosulfinates [22-24]. The sulfoxides, which are
responsible for the onion flavor and odor, might also be
responsible in part for the onion biological activity of
different Allium spp. species. The propanethiol is sug-
gested to be the main source of the characteristic onion
odor [23,24].
In previous studies, the anti-allergic potential of the
extracts of Allium cepa L. [16,17] and its flavonoid quer-
cetin [18,19,25] has been reported using a mouse model
of ovalbumin (OVA)-induced asthma. This study is the
first which was conducted using extracts of Allium cepa
L. (AcE) and quercetin treatment in murine model of al-
lergic airway disease induced by the sensitization to the
clinically relevant aeroallergen Blomia tropicalis mite.
This mite is a major house dust mite in dust worldwide
[26]. In addition, it has been shown that flavonoids, typ-
ically found in Allium cepa, have a relaxing effect on the
smooth muscle of isolated trachea and may have bron-
chodilator effect [25,27,28].
Thus, the objective of this study was to assess the thera-
peutic potential (anti-inflammatory and bronchodilator) ofthe methanolic extract of Allium cepa L. (AcE) and its
flavonoid quercetin (Qt) in a murine model of respiratory
allergy to Blomia tropicalis mite.
Methods
Animals
A/J mice aged 5–7 weeks (20–25 g), females, were from
the Fundação Oswaldo Cruz, Bahia, Brazil. Five animals
per group were used in each experiment. Mice were
housed in controlled temperature and humidity environ-
ment with 12-hour light–dark cycles, and had free access
to food and water. The experimental procedures were ap-
proved by the Ethical Committee for Use of Experimental
Animals of the Faculdade de Odontologia, Universidade
Federal da Bahia, Brazil (protocol number: 02/09).
Sensitization and challenge of mice with Blomia tropicalis
(Bt-sensitized mice)
A B. tropicalis extract was obtained as previously described
[15]. The experimental model of allergy to B. tropicalis (Bt)
dust mite was used as previously described [29]. The an-
imals were sensitized with subcutaneous injections of Bt
(100 μg of protein) adsorbed to 4 mg/ml of Al(OH)3 in sa-
line on days 0 and 7, and 1 day after the last sensitization
the animals received four intranasal challenges with Bt
(10 μg/instilation) every other day. Animals were eutha-
nized with intraperitoneal injections of xilazine and keta-
mine (40 mg/kg/body weight), 24 hours after the last
challenge. A schematic diagram of the sensitization and
allergen challenge schedule is shown in Figure 1.
Preparation of the Allium cepa L. extract and obtaining of
quercetin
A methanolic extract was obtained by maceration of
Allium cepa L. previously peeled and cut in a closed
container containing 1000 ml of 99.8% methyl alcohol
(CH3OH) during 7 days at room temperature. Subse-
quently, we proceeded to filtration of the extractive li-
quid, which then was rota-evaporated at a temperature
of 60–70°C in a thermostatic bath. This concentration
process was repeated three times. The AcE was dried in
the oven and then maintained at −20°C until use.
The flavonoid quercetin [2-(3, 4-dihydroxyphenyl)-3,
5, 7-trihydroxy-4H-1-benzopyran-4-one, 3, 3′, 4′, 5, 6 -
entahydroxyflavone] was obtained commercially (98%
purity) from Sigma-Aldrich® (St. Louis, MA, USA).
In vitro, different concentrations of AcE—10 μg/ml
(AcE10), 100 μg/ml (AcE100), or 1000 μg/ml (AcE1000),
and Qt—3.5 μg/ml (Qt3.5), 7.5 μg/ml (Qt7.5) or 15 μg/ml
(Qt15) were tested. In vivo, the tested groups were
animals sensitized to Bt and daily treated orally with
AcE containing 100 mg/kg (AcE100) and 1000 mg/kg
(AcE1000) or 30 mg/kg Qt (Qt30) dissolved in saline (ve-
hicle) from the 8th to the 14th day of the experimental
Figure 1 Representation of the asthmatic response (A) and experimental design of allergy to B. tropicalis (Bt) in B.
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with Bt. Mice receiving the following treatments were
studied: non-sensitized and vehicle-treated mice (negative
control group); Bt, Bt-sensitized mice and vehicle-treated
mice (positive control group); Bt/AcE100, Bt-sensitized
and AcE100-treated mice; Bt/AcE1000, Bt-sensitized and
AcE1000-treated mice; Bt/Qt, Bt-sensitized and Qt30-
treated mice (tested groups).
Standardization of Allium cepa L. extract
The major flavonoid found in Allium cepa L. is quercetin
[30,31]. The AcE was standardized in terms of quercetin
concentration by high performance liquid chromatog-
raphy, with ultraviolet light detection at 250 nm, using a
C-18 column (150 × 4.6 mm ID, 5 μm particle size,
Thermo Scientific) and a C-18 pre-column (Phenomenex,
Torrance, USA). The mobile phase consisted of 0.1%
aqueous formic acid (A) and methanol (B) at a flow rate of
1.0 ml/min. The following gradient elution method was
used for separation: 5% to 90% of B in A in 30 min. The
injection volume was 20 μL and quercetin calibration
curves were in the range of 5 to 100 μg/ml.Cell viability assay
Cell viability after in vitro exposure to AcE and Qt was
determined using the MTT assay. Spleen cells were
seeded at a density of 5 × 105 cells/well in 96-well plate
and were then exposed to AcE and Qt diluted in RPMI.
After 48 hours of incubation, the viability of the cells
was evaluated by using FCS-free medium containing
1 mg/ml of 3-[4, 5-dimethylthiazol-2-yl]-2, 5 diphenylte-
trazoliumbromide (MTT, Sigma). After 4 hours of incu-
bation at 37°C, the medium was discarded and the
formazan blue dissolved with DMSO. The optical dens-
ity (OD) was measured at 540 nm. The percentage of vi-
able cells was calculated by defining the cell viability
without treatment as 100%.
In vitro cytokine production by spleen cells
Levels of IL-4, IL-5 and IL-13 T-helper (Th) type 2 cyto-
kines in splenocytes cultures were evaluated. According
to the method described by Bezerra-Santos [32], spleno-
cytes from Bt-sensitized mice were washed twice in
RPMI medium by centrifugation at 200 × g for 10 min.
The obtained pellet was resuspended in RPMI medium
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penicillin, 100 μg/ml streptomycin, 5β-mercaptoethanol
and 10% fetal calf serum (Gibco, Pisley, UK). Viable cells
number was determined in a hemocytometer by exclusion
using trypan blue. The spleen cells were plated in 96-well
flat-bottomed tissue culture plates (Costar, Cambridge,
MA, USA) at a density of 5 × 105 cells/well. The cells were
treated with non-cytotoxic concentrations of AcE or Qt
and stimulated with 5 μg/ml of pokeweed (PWM) (Sigma
Aldrich, Saint Louis, MA, USA). The cells were incubated
at 37°C in a humidified atmosphere of 5% CO2 for
48 hours. Supernatants of the cell cultures were collected
and analyzed by enzyme-linked immunosorbent assay
(ELISA) for IL-4, IL-5 and IL-13 cytokine concentrations
(BD Pharmingen, San Diego, CA, USA).
In vitro airway smooth muscle relaxation
AJ mice were euthanized and the trachea was rapidly re-
moved. The trachea was cleared of loose connective tis-
sue and divided into 2 rings of 2 mm, containing on
average three to four cartilage bands. The rings were
suspended on metal rods, attached to a force transducer
(FORT10 WPI, Sarasota, USA) and placed in tanks for
isolated organ with Krebs-bicarbonate solution (compos-
ition in mM: NaCl 119, NaHCO3 25, CaCl2 × H2O 1.6,
KCl 4.7, KH2PO4 1.2, MgSO4 × 7H2O 1.2 and glucose
11.1), aerated with a carbogen mixture (95% O2 and 5%
CO2) and maintained at 37°C. After the stabilization
period (1 hour at 0.5 g), the rings were contracted with
10 μM of carbachol (Cch; Sigma, St Louis, MA, USA)
to assess the contractile state of the tissue and to evalu-
ate the presence of functional epithelium. The rings,
after reaching a plateau of contractile state, were stimu-
lated with bradykinin (Bk; Sigma, St Louis, MA, USA)
(10−6 M). The rings were again contracted with Cch
(10 μM) and cumulatively increasing concentrations of
AcE or Qt were added. Concentration response curve
was constructed and data were analyzed. Additionally,
the tracheal rings were previously exposed to IL-13 in
culture as described previously [33] to evaluate the ef-
fects of AcE or Qt on the hyper-responsive airway
smooth muscle. The rings were placed individually in
each well of a 48-well plate and incubated at 37°C in
the presence or absence of IL-13 (10 ng/ml, 24 hours;
BD Pharmingen, San Diego, CA, USA) in supplemented
Dulbecco’s modified Eagle’s medium (containing 25 mM
D-glucose, 1 mM sodium pyruvate, 100 U/ml penicillin,
100 μg/ml streptomycin, 0.2 M L-glutamine, 2.5 μg/ml
Fungizone, and 0.1% w/v bovine serum albumin) (Sigma, St
Louis, MA, USA) for 24 hours. Cumulative concentration-
response curves to Cch after incubation in the absence or
presence of IL-13 was built to analyze the hyper-reactivity
of smooth muscle. After that, concentration-response
curved for AcE or Qt was built.Collection of bronchoalveolar lavage (BAL) fluid and cell
counting
The trachea of the euthanized mice were canulated and
BAL fluid was obtained by three successive aspirations (total
volume 1.5 ml) via tracheal cannulation of phosphate buff-
ered saline, pH 7.4 (PBS) containing 1% of bovine serum al-
bumin (Sigma-Aldrich St. Louis, MA, USA). Total number
of leukocytes in the BAL was determined using Trypan blue
and differential cell counts for eosinophils were performed
by using Wright-stained cytospin preparations. Differential
counts of eosinophils of at least 100 cells were made in a
blind fashion in accordance with standard morphologic
protocol. The concentrations of IL-4, IL-5 and IL-13 in BAL
were quantified by ELISA, as recommended by the manu-
facturer (BD Pharmingen, San Diego, CA, USA).
Eosinophil peroxidase (EPO) activity in lung
The cell suspensions from mouse lungs were frozen and
thawed three times in liquid nitrogen. After centrifuga-
tion at 4°C for 10 min at 1000 g, the cell lysates were
placed into wells of 96-well plates, followed by the
addition of the chromogen and substrate solution
(1.5 mmol/L of o-phenylenediamine and 6.6 mmol/L of
H2O2 in 0.05 mol/L Tris–HCl, pH 8.0). After 30 minutes
room temperature, the reaction was stopped with the
addition of 0.2 mol/L citric acid, and the absorbance of
the sample determined at 492 nm in an ELISA reader.
Measurement of serum levels of Bt-specific IgE
Anti-Bt IgE antibody levels from mice were determined by
indirect ELISA. 96-well micro titer high-binding plate (Co-
star, Cambridge, MA, USA) were coated with Bt (100 μg/
well) overnight (at 4°C). The serum samples were added
and the plates were incubated again. Biotin-conjugated IgE
anti-mouse (BD Pharmingen, San Diego, CA, USA) were
added to the wells and incubated during 1 hour at room
temperature (RT). A solution of avidin-horseradish perox-
idase (BD Pharmingen, San Diego, CA, USA) was then
added to each well for 30 minutes. After that, a solution
containing 3, 3′, 5, 5′-tetramethylbenzidine and hydrogen
peroxide (BD Pharmingen, San Diego, CA, USA) was
added and incubated during additional 30 minutes (at RT).
The reaction was stopped with 4 M sulfuric acid. Between
all steps the wells were washed 3 times with PBS containing
0.05% Tween 20 (PBS-T). The absorbance of each sample
was determined at 492 nm in an ELISA reader.
Lung histology
The analyses the histopathological changes and the de-
gree of inflammation in peribronchiolar and perivascular
regions were performed. The lungs were perfused, via
the heart right ventricle, to remove residual blood, and
immersed in 10% (v/v) formaldehyde (Sigma-Aldrich St.
Louis, MA, USA). The tissue was dehydrated, embedded
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stained with hematoxylin-eosin (HE) for inflammatory
cell infiltration and were then stained with periodic acid-
Schiff (PAS) for the evaluation of mucus production,
under light microscopy with 40× magnification.
Statistical analysis
Multiple comparisons were performed by one-way ana-
lysis of variance (ANOVA) and Tukey’s post-test (for data
with normal distribution). Data were expressed as mean ±
standard error of the mean. Differences in p values ≤0.05
were considered statistically significant. Each experiment
was repeated at least twice.
Results
Quercetin is present in the methanolic extract of Allium cepa L
The chromatogram of the methanolic extract of AcE
(Figure 2A) and a quercetin standard solution (Figure 2B)Figure 2 Chromatogram of samples subjected to high performance li
extract. (B) Chromatogram of quercetin. Retention times of 22.51 minutes ademonstrated the separation of a compound in the
methanolic extract with the same retention time of Qt
in the standard sample (Figure 2A and B). The calcu-
lated average percentage of Qt in the AcE extract is 2.5%
(based on peak area).
Effect of AcE and Qt on cell viability and cytokine levels
in spleen cells culture
The non-cytotoxic concentrations of AcE and Qt used were
determined by MTT assay. As can be seen in Figure 3A,
none of the evaluated concentrations were toxic for spleen
cells (AcE: 1000–10 μg/ml and Qt: 15–3.75 μg/ml). The
production of Th2 cytokines, including IL-4, IL-5, and IL-
13 by PWM-stimulated splenocytes from Bt-sensitized mice
was increased in comparison to that by PWM-non-
stimulated splenocytes from Bt-sensitized mice (p < 0.001).
IL-4 (Figure 3B), IL-5 (Figure 3C), and IL-13 (Figure 3D)
levels were significantly lower in the culture supernatantsquid chromatography. (A) Chromatogram of Allium cepa L. methanol
re shown above peaks in (A) and (B).
Figure 3 Effect of the in vitro treatment with AcE or Qt on cell viability (A) and on the levels of IL-4 (B), IL-5 (C) and IL-13 (D). The
following groups were presented: splenocytes supernatant from animals Bt-sensitized without stimulation (control), stimulated with PWM (PWM)
and stimulated with PWM and exposed to different concentrations of AcE (10 μg/ml, 100 μg/ml or 1000 μg/ml) or Qt (3.75 μg/ml, 7.5 μg/ml, or
15 μg/ml). Values represent mean ± SEM (n = 5, per group). ###p < 0.001 vs. control, and ***p < 0.001, **p < 0.01 vs. PWM group (one-way ANOVA
followed by Tukey’s test).
Oliveira et al. DARU Journal of Pharmaceutical Sciences  (2015) 23:18 Page 6 of 12of splenocytes from PWM-stimulated mice that had
been treated with AcE or Qt, when compared to the
control group.
Effect of AcE and Qt on airway smooth muscle
contractility
As can be seen in Figure 4(A and C), the cumulative
addition of AcE (1, 3, 10, 30, 102, and 3 × 102 μg/ml) and
Qt (10−8, 10−7, 10−6, 10−5, 10−4, and 10−3 M), respectively,
induced a transient relaxing effect, in a concentration-
dependent manner, with the values of CE50 = 7.1 (1.8 –
27.4) mg/ml and CE50 = 8.9 (4.8 – 16.2) × 10−5 M for AcE
and Qt, respectively. The data set may be seen in Figure 4
(B and D), which shows an ACE concentration-response
curve. The percentage of the maximum relaxation (Emax)
induced by AcE was Emax = 47.2 ± 7.0 (%), and induced
by Qt was Emax = 84.0 ± 13.1 (%).
Additionally, in our in vitro model of hyper-reactivity
using IL-13, murine tracheal rings that were incubated
overnight with IL-13 (10 ng/ml) increased the constrictor
responses to Cch but without changes in pharmacologicalpotency (Emax = 0.84 ± 0.08 (%); pD2 = 6.8 ± 0.1091) when
compared with non-treated rings Emax = 0.55 ± 0.04 (%);
pD2 = 6.4 ± 0.1887 (Figure 4E). Moreover, a reduction in
intensity of smooth muscle contraction in the absence or
presence of IL-13 with different concentrations of AcE
(CE50 = 0.075 (0.011-0.5) Emax = 25.14 ± 5.52 (%)) or Qt
(pD2 = 4.6 ± 0.07 Emax = 104.42 ± 2.94 (%) was observed
(Figure 4F and G). However, the efficacy and potency of
the tested drugs in hyper-reactive tracheal rings (sensitized
with IL-13) were not altered when the drugs were tested
in normal rings, not sensitized with IL-13.
Effect of AcE or Qt on cell influx in BAL fluid and on EPO
levels in lungs
We examined changes in total cell numbers in the BAL
fluid to determine the effects of AcE or Qt on experimen-
tal respiratory allergy. The BAL cellularity was estimated
by counting the cells recruited to the BAL fluid 48 h
after the last challenge. In relation to the control group,
Bt-sensitized mice displayed a significant increase in total
cell numbers (p < 0.01). However, in Bt-sensitized mice, the
Figure 4 Effect of AcE or Qt in mice airway smooth muscle. A and C) The original record, the arrows indicate the time of addition of AcE (1, 3, 10,
30, 102 and 3 × 102 /ml, cumulatively) and Qt (10−8, 10−7, 10−6, 10−5, 10−4 and 10−3 M). B and D) Logarithmic concentration–response curve of relaxant
response of AcE (Emax = 47.2 ± 7.0 (%) EC50 = 7.1 (1.8-27.4) mg /ml) and Qt (Emax = 84.0 ± 13.1 (%), EC50 = 8.9 (4.8 to 16.2) × 10−5 M) on tracheal rings
pre-contracted with 1 μM carbachol, in the absence of functional epithelium (n = 6). E) Concentration-response curve of tracheas isolated from AJ mice
without epithelium pre-treated with IL-13 (■) or absence of IL-13 (•) and pre-contracted with Cch (10−9 M - 10−4 M). The concentration-response curve
was significantly higher in rings pretreated with IL-13 compared with absence of IL-13. Values are expressed as means ± SEM. *p < 0.05 and **p < 0.01
vs. tracheas absence of IL-13. The data were examined using unpaired Student’s t-tests. F and G) Concentration-response curves showing the relaxant
effect of AcE and Qt in tracheas rings denuded epithelium pre-contracted or not with IL-13 (n = 6).
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(p < 0.05) decreased the total number of cells in relation
to untreated Bt-sensitized mice (Figure 5A). Additionally,
the lung tissue was collected 48 hours after the final
Bt challenge and EPO activity were measured. The EPO
levels from lung tissue of Bt-sensitized mice were increased
in relation to control group (p < 0.001). The mice from
Bt-sensitized group and treated with AcE100 (p < 0.001) or
AcE1000 (p < 0.001) had significantly lower EPO levels after
respiratory allergy induction. No effect in EPO levels was
observed in mice treated with Qt30 (Figure 5B).Effect of treatment with AcE or Qt on inflammatory cell
infiltration and amount of mucus in lungs
Because AcE or Qt inhibits inflammatory cell recruit-
ment into the lung tissue and EPO levels in lungs, we
examined the histology of lung tissue. In Bt-induced
asthmatic lung tissue, we observed a marked infiltration
of inflammatory cells into the perivascular and the peri-
bronchiolar regions (Figure 6A-E), and airway mucus hy-
persecretion (Figure 6F-J) compared with the normal
tissue. Cell infiltration and mucus hypersecretion in
lungs of Bt-sensitized were attenuated by treatment with
AcE when compared with the level seen in Bt-sensitized
mice, as shown in Figure 6.Effect of treatment with AcE or Qt on cytokine levels in
BAL fluid
To determine whether AcE or Qt influenced the generation
of a Th2-type immune response, cytokine concentrations in
BAL fluid (IL-4, IL-5 and IL-13) were measured by ELISA
24 hours after the last challenge. As shown in Figure 7,
Bt-sensitized animals had significantly higher IL-4 (p < 0.01),
IL-5 (p < 0.01) and IL-13 (p < 0.05) levels in the BAL fluid
than control mice. In Bt-sensitized mice the treatment
with AcE or Qt significantly decreased IL-4 and IL-5 levels
(p < 0.05) when compared with the levels seen in theFigure 5 Effect of AcE or Qt on the levels of total cells in the BAL and
of A) total cells counting B) eosinophilia in the BAL and C) eosinophil pero
(Bt); and Bt-sensitized, AcE (100 or 1000 mg/kg) or Qt (30 mg/kg) treated m
###p < 0.001 vs. control; *p < 0.05; **p < 0.01; ***p < 0.001 vs. Bt group (one-wBt-sensitized group. The oral treatment with AcE did not
affect the levels of IL-13 in the BAL of Bt-sensitized mice.
Effect of treatment with AcE or Qt on serum levels of
Bt-specific IgE antibodies
The cross-linking of allergen-specific IgE on the surface of
mast cells upon allergen challenge is relevant to the initi-
ation of the early asthmatic reaction. The serum levels of
Bt-specific IgE were measured 24 hours after the last chal-
lenge. We observed that sensitization and challenge with
Bt resulted in increased serum levels of Bt-specific IgE
when compared with non-sensitized animals (p < 0.001).
The treatment of sensitized mice with AcE or Qt did not
reduce significantly Bt-specific IgE (Figure 8).
Discussion
The chronic inflammatory response to allergens on aller-
gic asthma is characterized by eosinophilia, airway hyper-
responsiveness (AHR) and increased mucus production.
The actions of inflammatory cells in airways are tightly
regulated by a network of Th2 cytokines, such as IL (inter-
leukin)-4, IL-5, and IL-13 [34]. The present study was con-
ducted using a murine model of allergic airway disease
induced by Blomia tropicalis mite that was previously
characterized by our research group [29]. Previous studies
show that once Bt sensitization induced cells infiltration
to the lungs, increased EPO activity and high amounts of
Bt-specific IgE were obsrved. All these were associated to
a Th2-type cytokine profile (with the production of IL-5,
IL-13 and IL-4), which is important for the development
and maintenance of the Th2 response characteristic of
asthma [29,15]. The resolution of inflammation is funda-
mental to the return of normal physiological parameters.
In this study we observed that Allium cepa L. and
quercetin were associated to anti-inflammatory and bron-
chodilator activities in an airway inflammation murine
model of asthma. As previously described [29], the total
BAL cell numbers were increased in Bt-sensitized mice.on EPO in lungs. Effect of the treatment with AcE or Qt on the level
xidase (EPO) activity in lung tissue. Control (Ctrl); Bt-sensitized animals
ice. Values represent mean ± SEM (n = 5, per group). ##p < 0.01;
ay ANOVA followed by Tukey’s test).
Figure 6 Effect of the treatment with AcE or Qt on celular infiltration and mucus production in lung tissues. Sections were stained
with hematoxylin-eosin (magnification × 400) (A-E) and sections were stained with periodic acid-Schiff (magnification × 400) (F-J). (A and F)
Lung section from a control, saline-treated mice; (B and G) Lung section from a Bt-sensitized, saline-treated mice; (C and H) Lung section from a
Bt-sensitized, AcE 100 mg/kg treated mice; (D and I) Lung section from a Bt-sensitized, AcE 1000 mg/kg treated mice; (E and J) Lung section
from a Bt-sensitized, Qt 30 mg/kg treated mice.
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in total cell numbers in the groups of Bt-sensitized ani-
mals treated with AcE10, AcE1000, or Qt30. Drugs that
modulate the recruitment of eosinophils and their activa-
tion may be important in reducing lung inflammation in
asthma [35,29,36]. AcE and Qt when administered to al-
lergic mice induce a decrease in total cellularity in BAL, a
parameter required to suppress eosinophil degranulation.Despite the fact that Qt30 did not significantly modulate
EPO in the lung, the Bt-sensitized mice treated with
AcE100 or AcE1000 had significantly lower EPO levels than
untreated Bt-sensitized control mice, suggesting that a
substance other than Qt is mediating this effect in AcE.
Previous studies in humans have shown that the addition
of anti-IL-5 monoclonal antibody on asthma therapy
significantly accelerated apoptosis of eosinophils, thereby
Figure 7 Effect of AcE or Qt on cytokine levels in BAL fluid. Effect of the treatment with AcE or Qt on the levels of A) IL-4 and B) IL-10
C) IL-13 in the BAL of Control (Ctrl); Bt-sensitized animals (Bt); and Bt-sensitized, AcE (100 or 1000 mg/kg) or Qt (30 mg/kg) treated mice. Values
represent mean ± SEM (n = 5, per group). #p < 0.05 vs. control; ###p < 0.001 vs. control; **p < 0.01 vs. Bt group and ***p < 0.001 vs. Bt group
(one-way ANOVA followed by Tukey’s test).
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could observe a significant reduction of IL-5, accompanied
by a significant decrease in eosinophil peroxidase in the
lungs of sensitized mice treated with Bt and AcE.
AcE and Qt had a statistically significant inhibitory ef-
fect on IL-4 and IL-5 levels in the BAL fluid of mice
treated with AcE100 and Qt30. Despite the modulation of
IL-13 in vitro, a similar effect could not be observed
in vivo. AcE and Qt suppressed the secretion of IL-4, IL-5
and IL-13 by spleen cells stimulated with PWM. This fact
reinforces the importance of in vivo studies to elucidate
the mechanisms involved in drug activities.Figure 8 Effect of AcE or Qt on the levels of IgE anti-Bt. Effect of
the treatment with AcE or Qt on the level of IgE in control (Ctrl);
Bt-sensitized animals (Bt); and Bt-sensitized, AcE (100 or 1000 mg/kg)
or Qt (30 mg/kg) treated mice. Antibody levels were measured by
indirect ELISA. Values represent mean ± SEM (n = 5, per group).
###p < 0.001 vs. control (one-way ANOVA followed by Tukey’s test).IL-4 along with IL-5 modulates eosinophil activation
to stimulate B cells, IgE production, and mast cell de-
granulation [38] and their reduction, has been shown in
this study, could be involved in the modulation of symp-
toms of allergic disease.
IL-13 also plays important role in allergic asthma
[33,34], such as eosinophilic lung infiltration and mucus
hypersecretion [39,40], which could be observed in our
allergic mice. As there was no significant modulation of
IL −13 by the tested drugs, we believe that in this work,
as well as in other prior work, mucus is strongly con-
nected to increased levels of IL-13 on asthmatic mice
[40]. Nevertheless, AcE (AcE100) was able to decrease
the amount of mucus in the lungs of treated and Bt-
sensitized mice. This effect was not observed with Qt30.
Regarding IgE levels, no reduction on antibody titers
were observed. These results may be related to the lack of
a modulating effect on IL-13, which in addition to IL-4, is
an important regulator of IgE production. Another hy-
pothesis to explain the absence of effect on IgE levels is re-
lated to the short duration of our acute model, which may
not be suitable for evaluating humoral responses, consid-
ering the necessary time for the variation in certain cyto-
kine levels to reflect on serum antibody concentrations.
The interaction between the allergen and IgE present
on mast cells plays a critical role in allergic inflamma-
tion. IgE cross-linking on mast cells leads to the release
of histamine, prostaglandin (PG) D2 and leukotrienes,
which results in smooth muscle contraction, mucous se-
cretion and vasodilatation [41,42]. In previous studies
[25,27,28], the therapeutic potential of flavonoids in iso-
lated trachea was investigated. In this study it was ob-
served that both AcE and Qt exerted a relaxing activity
on the smooth muscle of isolated murine trachea pre-
contracted with Cch. Additionally, our study supports
the findings that interleukin-13 has been implicated as
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asthma, since we demonstrated an increased contractility
in response to Cch in airway smooth muscle induced by
IL-13 [33]. Significant changes in Emax were observed,
indicating that IL-13 seemed to increase smooth muscle
contractility and cause hyperreactivity at the level of
contractions. However the bronchodilatory potential of
AcE or Qt is not selective for IL-13-induced hyperactiv-
ity pathway, as there was no difference between their
effect on hyperreactive smooth muscle (IL-13- sensi-
tized) and their effect on normal smooth muscle.
This study corroborates other previous studies on the
anti-inflammatory and antiallergic properties of Allium
cepa L. and quercetin [16-19,25], which might be linked
to the ability of AcE an quercetin in down-modulate in-
flammatory processes through different signaling path-
ways such as NF-κB [43-45]. On the other hand, some
authors discuss allergic reaction to onion. In such previous
studies regarding onion hypersensitivity, authors reported
patients producing IgE as well as cell-mediated mecha-
nisms against plant lipid transfer proteins (LTPs) [46].
These are a group of highly-conserved proteins found in
higher plant tissues [47]. The hypersensitivity to onion has
been described as a cause of asthma induced by handling
of onions. However, few publications in the literature re-
port allergic reactions due to onion ingestion despite its
wide use [48]. No toxic effect was found in animals ex-
posed to AcE in the present study (data not shown).
AcE displayed a greater efficacy when compared to Qt,
as it was able to regulate a greater amount of the param-
eters evaluated. This research corroborates with previous
studies of natural products, which state that better bio-
logical responses can be achieved by the additive or syn-
ergistic effects of different compounds from an extract
[49]. However, further studies are required in order to
elucidate the cellular and molecular mechanisms by
which AcE performs its action and to determine what
substances are present in AcE in addition to quercetin,
that contribute to the observed biological responses.
Conclusions
The results obtained in this work provide the first evi-
dence that Allium cepa L. may have an anti-allergic effect
more intense than Qt, and may be a future target for new
molecules to treat allergic asthma. Our work may also val-
idate and explain the long-held traditional use of this spe-
cies by folk Brazilian medicine to treat asthma. This work
also opens new perspectives in the context of elucidating
the cellular and molecular mechanisms involved in the
mechanism of action of Allium cepa L. as a way to enable
clinical trials to evaluate its efficacy in humans.
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